Patent application number | Description | Published |
20090244710 | HARD-COATED ANTIGLARE FILM, AND POLARIZING PLATE AND IMAGE DISPLAY INCLUDING THE SAME - A hard-coated antiglare film, comprising a transparent plastic film substrate and a hard-coating antiglare layer containing fine particles on at least one surface of the transparent plastic film substrate, wherein an arithmetic average surface roughness Ra (μm) that is defined in JIS B 0601 (1994 version) is in the range of 0.05 to 0.15 μm in an uneven shape of a surface of the hard-coating antiglare layer, and the hard-coated antiglare film includes at least 80 convexities that exceed a roughness mean line of a surface roughness profile in a 4-mm long portion at an arbitrary location of the surface of the hard-coating antiglare layer. | 10-01-2009 |
20110080643 | HARD-COATED ANTIGLARE FILM, POLARIZING PLATE AND IMAGE DISPLAY INCLUDING THE SAME, AND METHOD FOR EVALUATING THE SAME - A hard-coated antiglare film that has superior antiglare properties, and reflection properties even when a haze value is low, and can improve the depth of black in black display by preventing “tinting” occurs specifically when a reflection is reduced, a polarizing plate, and the like. The film has a reflection intensity ratio of 3 or less, a hard-coating antiglare layer containing fine particles, and an antireflection layer. A surface of the antireflection layer has an uneven shape, and an average angle of inclination θa and an arithmetic average surface roughness Ra in predetermined ranges. At the surface of the antireflection layer, convexities exceeding a roughness mean line of a surface roughness profile in a predetermined number range, and convexities exceeding a standard line that is in parallel with the mean line and is located at a height of 0.1 μm in predetermined size and number ranges are included. | 04-07-2011 |
20110080644 | HARD-COATED ANTIGLARE FILM, POLARIZING PLATE AND IMAGE DISPLAY INCLUDING THE SAME, METHOD FOR PRODUCING THE SAME, AND METHOD FOR EVALUATING THE SAME - A hard-coated antiglare film that has an extremely low haze value, superior anti-fluorescent lamp glare properties, and anti-face glare properties, and can improve the depth of black in black display by preventing white blur from occurring, a polarizing plate, and the like. The hard-coated antiglare film includes: a transparent plastic film substrate; and a hard-coating antiglare layer containing fine particles, which is on at least one surface of the transparent plastic film substrate, and has a total haze value in a range of 0% to 5%. The number N | 04-07-2011 |
20110080645 | HARD-COATED ANTIGLARE FILM, POLARIZING PLATE AND IMAGE DISPLAY INCLUDING THE SAME, METHOD FOR PRODUCING THE SAME, AND METHOD FOR EVALUATING THE SAME - A hard-coated antiglare film that has superior antiglare properties, allow high definition to be provided even in the case of a low haze value, can prevent white blur in an oblique direction from occurring and, and can improve the depth of black in black display, as well as a polarizing plate, and the like. The hard-coated antiglare film includes a transparent plastic film substrate and a hard-coating antiglare layer containing fine particles, which is on at least one surface of the transparent plastic film substrate. The hard-coated antiglare film has a total haze value Ht in the range of 10% to 35%. The total haze value Ht and an internal haze value Hin satisfy a relationship of 0.5≦Hin/Ht≦0.9. The surface of the hard-coating antiglare layer has an uneven shape and an arithmetic average surface roughness Ra in the range of 0.1 to 0.3 μm. The hard-coated antiglare film includes: convexities that exceed a roughness mean line of a surface roughness profile; no convexities in which line segments of portions of the mean line that cross the convexities each have a length of 80 μm or longer, and convexities that exceed a standard line that is in parallel with the mean line and is located at a height of 0.1 μm; and at least 50 convexities in which line segments of portions of the standard line that cross the convexities each have a length of 20 μm or shorter in 4-mm long portion at an arbitrary location of the surface of the hard-coating antiglare layer. | 04-07-2011 |
Patent application number | Description | Published |
20090264664 | PREPARATION FOR EXTERNAL APPLICATION COMPRISING SALT OF MAST CELL DEGRANULATION INHIBITOR HAVING CARBOXYL GROUP WITH ORGANIC AMINE - Mast cell degranulation inhibitors having a carboxyl group have not been developed as external preparations due to the low transdermal permeability thereof. By formulating external preparations thereof, side effects on the internal organs by oral administration can be avoided. Some of the mast cell degranulation inhibitors show drastically inferior photostability, which is also one cause of suppressed development of the drug as an external preparation. | 10-22-2009 |
20110092438 | Composition for external application comprising transcription factor decoy as active ingredient - The present invention provides an external preparation composition of transcription factor decoy of good skin permeability, the composition comprising a transcription factor decoy dissolved in a fatty acid-based ionic liquid obtained from a fatty acid having 2 to 20 carbon atoms and an organic amine compound having 4 to 12 carbon atoms. | 04-21-2011 |
20110294860 | AQUEOUS ORAL PREPARATION OF STABLE AMLODIPINE - The invention provides a stable and rapidly disintegrable aqueous oral preparation (liquid or jelly preparation) of amlodipine. The liquid preparation comprises an anionic surfactant having a sulfuric acid group or a sulfonic acid group as a stabilizer in an aqueous solution of amlodipine, at pH 5-7, while the jelly preparation further comprises a gelling agent, a fine powder solid, and a gelling regulator. | 12-01-2011 |
20120029434 | APPLICATOR FOR MICRONEEDLE ARRAY - Provided is a microneedle device which protects microneedle, has an easily portable shape, is free from such problems as breakage of small needles in the step of puncturing the skin with the microneedle, and ensures appropriate skin puncture for administering a drug. By studying the relationship between a device to be pressed to the skin and the height of an elevation on the skin surface under the pressing and thus producing a device equipped with microneedle that are embedded in a concave part having a definite depth, the microneedle can be surely and easily inserted and punctured into the skin while avoiding such problems as breakage of the small needles of the microneedle. Thus, a microneedle patch formulation, which is easily portable and ensures convenient drug administration to the skin, can be produced. | 02-02-2012 |
20120080119 | MEDICATION LIQUID SUPPORTING JIG AND METHOD OF APPLYING MEDICATION TO MICRO-NEEDLE USING SAME - Provided are a jig for uniformly applying a drug liquid to a microneedle, and a method of applying a drug to a microneedle using same. Grooves of a number corresponding to the number of rows of small needles of a microneedle are formed in the surface of a flat plate jig or of a roller-like jig, and a drug liquid is filled and held in the grooves. The drug liquid is applied to the microneedle by inserting the small needles of the microneedle into the surface of the drug liquid held in the narrow grooves, and immersing the small needles in the drug liquid. By this, the drug liquid is uniformly applied to the small needles of the microneedle without unevenness between the central section and the peripheral section of each microneedle, and thus the microneedles having good quality can be easily manufactured. | 04-05-2012 |
20120184916 | APPLICATOR DEVICE OF PINHOLDER TYPE MICRONEEDLE - Provided is a microneedle device which protects a microneedle, has an easily portable shape, is free from such problems as breakage of small needles in the step of puncturing the skin with the microneedle, and ensures appropriate skin puncture to administer a drug. By studying the relationship between the device to be pressed to the skin and the height of the elevation of the skin surface during the pressing, it is found that there is a positive correlation between the placement and interval of skin fixing members and the height of the elevation of the skin. It is furthermore found that the elevated skin surface is always parallel to the flat plate of the device. This reveals that since the microneedle installed in the device can be inserted at right angle to the skin surface, the skin can reliably be punctuated avoiding the breakage etc. of the small needles of the microneedle. Thus, a microneedle patch which is easily portable and ensures convenient drug administration to the skin can be produced. | 07-19-2012 |
20130006187 | ADHESIVE PATCHING AID FOR MICRONEEDLE ADHESIVE SKIN PATCH - The invention provides an applicator that holds a microneedle to facilitate puncture of the skin and includes an assisting tool as a supporting base to set the microneedle and an adhesive sheet such as a tape and the like, on the side face of the assisting tool to enable close adhesion of the microneedle puncturing the skin. | 01-03-2013 |
20130296790 | MICRONEEDLE - Provided are a microneedle and a microneedle array which have both aspects of safety and easiness to use and can administer a predetermined dose of a medical agent without causing a pain by smoothly running into the skin surface layer of a patient,
| 11-07-2013 |
Patent application number | Description | Published |
20100234471 | LIDOCAINE TAPE PREPARATION - The present invention discloses a novel tape preparation containing lidocaine at a high concentration. A tape preparation containing lidocaine at a high content, which has a lidocaine contant of 10 w/w % or more, can be produced by using a lactic acid salt of lidocaine, while preventing the precipitation of a crystal of lidocaine. | 09-16-2010 |
20100280090 | TAPE PREPARATION COMPRISING ETODOLAC IN IONIC LIQUID FORM - Disclosed is a tape preparation comprising etodolac in an ionic liquid form, which has high transdermal absorbability. Etodolac is reacted with an organic amine compound to produce an ionic liquid of etodolac. By using the ionic liquid, it becomes possible to increase the transdermal absorbability of etodolac. Further for the purpose of enhancing the transdermal absorbability and the tissue penetration ability of an ionic solution of etodolac, the composition of an organic solvent system for the ionic solution of etodolac is investigated, and it is found that a mixed solvent of an alcohol and an ester (1:2 to 2:1) is suitable as the organic solvent. Still further, an appropriate adhesion force can be achieved by properly selecting a softening agent. In this manner, a tape preparation having good transdermal absorbability can be prepared. The tape preparation can exert its pharmacological efficacy rapidly, and is therefore extremely effective for the teatment of a chronic pain such as rheumatoid arthritis, osteoarthritis and lumbago, an inflammatory diseases such as shoulder periarthritis and tendovaginitis, cervical syndrome, a pain induced by a surgery or an injury, or the like. | 11-04-2010 |
20110152377 | EXTERNAL PREPARATION COMPRISING FATTY ACID SALT OR BENZOIC ACID SALT OF BASIC PHARMACOLOGICALLY ACTIVE COMPONENT, AND METHOD FOR PRODUCTION THEREOF - It has been demanded to develop a formulation for a novel external preparation having excellent transdermal absorption of a basic pharmacologically active component contained therein. It is found that the lipid solubility (logP values) of a basic pharmacologically active component and an organic acid (particularly a fatty acid) contribute significantly to the transdermal absorption of the basic pharmacologically active component in the selection of proper combinations of the basic pharmacologically active component and the organic acid. Namely, it is found that superior transdermal absorption of a basic pharmacologically active component having a lipid solubility level of 0.5 to 5 can be achieved by forming a salt of the component with a fatty acid having a lipid solubility level of −1 to 4. Thus, it becomes possible to provide a novel external preparation having excellent transdermal absorption properties. | 06-23-2011 |
Patent application number | Description | Published |
20100004608 | PROCESS FOR PRODUCING MICRONEEDLE OF THERMOSENSITIVE SUBSTANCE - The invention provides a method of producing a microneedle. A jig is heated to a temperature above the level at which a temperature-sensitive material that exhibits thermoplastic deformation becomes viscoplastic, the jig is brought into contact with the temperature-sensitive material, and then the jig is pulled part from the temperature-sensitive material to elongate the portion of the temperature-sensitive material in contact with the jig, whereby acicular projections are formed. | 01-07-2010 |
20100029704 | SALT OF NONSTEROIDAL ANTI-INFLAMMATORY DRUG AND ORGANIC AMINE COMPOUND AND USE THEREOF - The invention provides a salt, particularly an ionic liquid, of a non-steroidal anti-inflammatory drug (NSAID) comprising a carboxylic acid and an organic amine compound, as well as a method of producing such a salt. | 02-04-2010 |
20100036002 | PHARMACEUTICAL COMPOSITION COMPRISING POROUS DRY MATRIX - The invention provides a porous dry matrix preparation comprising at least a polymeric thickener and an excipient ingredient, wherein (1) the content of the polymeric thickener is down to 0.5 w/w % and up to 14 w/w %, (2) the content of the excipient ingredient is down to 30 w/w % and up to 80 w/w %, (3) the void ratio is not less than 20%, and (4) the water activity is not more than 0.55, or water content is not more than 10 w/w %. | 02-11-2010 |
20130209660 | MICRO-NEEDLE COATING METHOD - Since all methods of applying a drug liquid to a tip portion of a microneedle are application of the drug liquid in an open system, evaporation of the solvent from the drug liquid is unavoidable, such that the concentration of the drug liquid changes easily, and a large amount of the drug liquid is necessary. The invention provides a method of applying a drug to a pin-frog-shaped microneedle by using a small amount of the solution and without variation of the concentration of the drug liquid. A member having plural grooves is produced, and one end thereof is immersed in a drug liquid tank to fill the grooves with the drug liquid. The drug can be uniformly applied to a tip portion of the microneedle by setting the pin-frog-shaped microneedle to pass through the drug liquid in the grooves. | 08-15-2013 |
Patent application number | Description | Published |
20080319003 | CYCLIC AMINE COMPOUND AND PEST CONTROL AGENT - A chemical compound represented by the formula [I]: | 12-25-2008 |
20090143443 | CYCLIC AMINE COMPOUND AND PEST CONTROL AGENT - The present invention is directed to novel cyclic amine compounds represented by the formula [I]: | 06-04-2009 |
20090259046 | Cyclic Amine Compounds and Agents for Pest Control - Agents for pest control comprising cyclic amine compounds represented by the formula (1) | 10-15-2009 |
20090318694 | Cross-Linked Amine Compounds and Agents for Pest Control - Cyclic amine compounds represented by formula (1) | 12-24-2009 |
20110251388 | 1-HETERODIENE DERIVATIVE AND HARMFUL ORGANISM CONTROL AGENT - The present invention provides a 1-heterodiene derivative represented by formula (2) or salt thereof: (in formula (2), W represents hydrogen atom or the like, A represents oxygen atom or the like, R | 10-13-2011 |
20110257389 | CROSS-LINKED CYCLIC AMINE COMPOUNDS AND AGENTS FOR PEST CONTROL - Cyclic amine compounds represented by formula (1) | 10-20-2011 |
20120225895 | 1-HETERODIENE DERIVATIVE AND PEST CONTROL AGENT - The present invention provides a pest control agent having a novel skeleton, which can be synthesized industrially, and also has excellent biological activity and residual effects. Specifically, the present invention provides a 1-heterodiene derivative represented by Formula (1) or a salt thereof, and a pest control agent including, as an active ingredient, a 1-heterodiene derivative or a salt thereof. | 09-06-2012 |
20120289700 | CYCLIC AMINE COMPOUND AND ACARICIDE - Provided is a cyclic amine compound, represented by the following formula (I) that has superior acaricidal activity, has superior properties and safety, and which can be synthesized industrially advantageously, a salt thereof and an acaricide: | 11-15-2012 |
20120309964 | CYCLIC AMINE COMPOUND AND ACARICIDE - The present invention provides a cyclic amine compound represented by formula (I) (in formula (I), Cy | 12-06-2012 |
20130331569 | CROSS-LINKED CYCLIC AMINE COMPOUNDS AND AGENTS FOR PEST CONTROL - Cyclic amine compounds represented by formula (1) | 12-12-2013 |
Patent application number | Description | Published |
20110210675 | Light source module and lighting apparatus, and illumination apparatus using same - A light source module includes a substrate unit for mounting multiple light emitting diodes thereon to electrically connecting them; first and second electrical connecting terminals for supplying a current to the light emitting diodes based on a voltage applied from outside the substrate unit; and a characteristic setting unit for presetting characteristic information corresponding to a electrical characteristic of the light emitting diodes. Further, the light source module includes a third electrical connecting terminal for outputting a setting signal based on the characteristic information preset in the characteristic setting unit, and the characteristic setting unit is connected at least between the third and first electrical connecting terminals or between the third and second electrical connecting terminals, and the characteristic setting unit responds to a set-up power inputted from the third electrical connecting terminal to generate the setting signal. | 09-01-2011 |
20110234104 | LOAD DETERMINATION DEVICE AND ILLUMINATION APPARATUS USING SAME - An illumination load determination device includes an illumination load; a voltage applying unit for applying a voltage to the illumination load; a connection unit for connecting the illumination load and the voltage applying unit; a detection unit for detecting at least one of a current flowing through the illumination load and a voltage across the illumination load when the voltage is applied to the illumination load from the voltage applying unit via the connection unit; and a determination unit for determining a type of the illumination load based on an output from the detection unit. The determination unit has a comparator for comparing a detection value detected by the detection unit to a predetermined threshold, and determines that the illumination load has a capacitance based on an output of the comparator. The voltage applying unit lights on the determined illumination load with a rated driving voltage. | 09-29-2011 |
20110248637 | ILLUMINATION DEVICE, LAMP, LIGHTING CIRCUIT, AND ILLUMINATION APPARATUS - An illumination device includes a replaceable lamp including at least one light emitting element; a lighting device for lighting the light emitting element by supplying a power to the lamp; and an illuminance correction unit for performing a dimming control on the lamp. The illuminance correction unit includes a timer for counting a cumulative lighting time of the light emitting element and a memory for storing the cumulative lighting time counted by the timer. The illuminance correction unit determines a dimming ratio of the light emitting element based on the cumulative lighting time stored in the memory and an illuminance correction characteristic, in which the relationship between the cumulative lighting time and the dimming ratio of the light emitting element is determined to uniformly maintain a light output from the light emitting element even when the cumulative lighting time increases. The memory is provided in the lamp. | 10-13-2011 |
20110260648 | LIGHT SOURCE MODULE, LIGHTING APPARATUS, AND ILLUMINATION DEVICE USING THE SAME - A light source module includes: a light source unit including a plurality of light-emitting diodes (LEDs) electrically connected to each other; a characteristic setting unit for setting characteristic information on electrical characteristics of the LEDs; a first pin base having a first electrode and a second electrode; and a second pin base having a third electrode and a fourth electrode, wherein a direct current (DC) voltage supplied from a lighting apparatus is applied between the first electrode and the second electrode or between the third electrode and the fourth electrode, a constant voltage is supplied to an anode side of the LEDs of the light source unit, and the characteristic setting unit is connected between the first and second electrodes and/or between the third and fourth electrodes. | 10-27-2011 |
Patent application number | Description | Published |
20100253233 | DISCHARGE LAMP LIGHTING DEVICE AND LIGHT FIXTURE - In order to suppress cost of an initial investment by a user and running cost to the user to a low extent while substantially constantly maintaining an apparent illuminance, and further, to realize resource saving, in a case of using a fluorescent lamp FHF | 10-07-2010 |
20110193495 | LIGHTING POWER SOURCE WITH CONTROLLED CHARGING OPERATION FOR DRIVING CAPACITOR - A lighting power source provides AC or DC power as needed to power an electric light source. A first switching element and a diode are coupled in series across output ends of a DC power source, with a second switching element coupled across the diode. An inductor forms an output loop with the diode. A driving capacitor has a first end coupled to a node between the first switching element and the diode. A charging power source is coupled to a second end of the driving capacitor and supplied with power from the DC power source. During a charging operation, a control circuit charges the driving capacitor by turning on the second switching element while maintaining the first switching element in an OFF state. During a normal operation which follows the charging operation the control circuit repeatedly turns on/off the first switching element while maintaining the second switching element in the OFF state. | 08-11-2011 |
20120153832 | LED LIGHTING DEVICE AND ILLUMINATION APPARATUS INCLUDING SAME - An LED lighting device includes a step-up chopper which includes a first switching element and increases an output voltage applied from a DC power supply, a step-down chopper which includes a second switching element and decreases the output voltage from the step-up chopper to apply the decreased output voltage to a light source unit having light emitting diodes, a controller which controls operations of the first and the second switching element, a current limiter which includes a current limiting element and a switch; and a voltage detection unit. The controller stops an operation of the first switching element when the voltage detection unit detects the voltage applied to the light source unit exceeding a predetermined voltage value, and the switch allows a current to flow through the path passing through the current limiting element when the operation of the first switching element is stopped. | 06-21-2012 |
20120153863 | LED LIGHTING DEVICE AND ILLUMINATION APPARATUS INCLUDING SAME - An LED lighting device includes a converter for converting a power source voltage into a DC voltage and outputting it to an LED unit; and a controller for controlling an output of the converter. The converter has a chopper circuit including a series circuit of an inductance element and a capacitor; a switching element connected to the inductance element in series and turned on/off by the controller; and a diode as discharging path of the inductance element during an OFF state of the switching element. The controller controls an on/off time of the switching element such that a current supplied to the LED unit during a specific time period after a lighting operation is started becomes smaller than a current supplied to the LED unit in a steady state by using a voltage generated in a secondary coil of the inductance coil as an operating voltage thereof. | 06-21-2012 |
20120161649 | LED LIGHTING DEVICE AND ILLUMINATION APPARATUS INCLUDING SAME - An LED lighting device includes a power converter for outputting a variable output voltage, two LED lamps being connected in series between output terminals of the power converter; a current detector for detecting an output current from the power converter; a first detector for detecting the output voltage of the power converter and generating a first detection voltage corresponding to the output voltage; a second detector for detecting an applied voltage to one of the two LED lamps and generating a second detection voltage corresponding to the applied voltage; and a controller for controlling the power converter to adjust the output voltage to thereby make the output current coincide with a target value. The controller controls the power converter to decrease the output voltage if at least one of the second detection voltage and the deference between the first and the second detection voltage does not fall within a range. | 06-28-2012 |
Patent application number | Description | Published |
20090008883 | High-Pressure Fuel Pump and Seal System For High-Pressure Fuel Pump - A high-pressure fuel pump with seal system that is usable under the conditions of “high speed”, “high pressure” and “fuel resistance”. There is provided a high-pressure fuel pump comprising an axle capable of reciprocating motion in the pump and seal system ( | 01-08-2009 |
20130175764 | OIL SEAL - An oil seal has a first seal member including a main lip and a first dust lip, and a second seal member installed in a machine outer side of the first seal member. The second seal member integrally has an end surface covering section covering an end surface section of a housing, an outer peripheral insertion section inserted from one side in an axial direction to an outer peripheral surface of the housing and engaged with a stepped engagement section in the outer peripheral surface of the housing so as to prevent the second seal member from coming off from the housing, an inner peripheral insertion section inserted to an inner peripheral surface of the shaft hole in the housing from one side in the axial direction, and a second dust lip slidably coming into close contact with the shaft in the machine outer side of the first dust lip. | 07-11-2013 |
20140077459 | VALVE STEM SEAL DEVICE - A valve stem seal device has a valve stem guide, a cylindrical metallic ring retained to an outer periphery of the valve stem guide, a rubbery elastic seal lip integrally formed in one end side of the metallic ring, and hermetically sliding to the valve stem, and a valve stem seal having the cylindrical metallic ring and the seal lip and fixed to the valve stem guide side. The valve stem seal device has a stop ring retained between a circular-truncated-cone-shaped surface which is expanded toward a side of the seal lip formed in an outer peripheral surface of the valve stem guide, and a cylindrical inner peripheral surface of the metallic ring. The stop ring has a cut part, and a movement limiting means for limiting a movement in an axial direction of the stop ring is provided in the other end side of the metallic ring. | 03-20-2014 |
Patent application number | Description | Published |
20100080288 | VIDEO COMPRESSION CODING METHOD AND APPARATUS - A first delay memory is input with an input image frame output from a ME (motion estimation) processor, and delays output to a first adder for carrying out a prediction residual generation process a predetermined time period. A second delay memory is input with an inter-prediction luminance image frame, and delays output to a prediction selection circuit a predetermined time period. A third delay memory is input with motion vector information output from the ME processor, and delays output of the motion vector information to an inter-prediction chrominance image creation processor a predetermined time period. | 04-01-2010 |
20100135381 | ENCODING/DECODING DEVICE AND VIDEO TRANSMISSION SYSTEM - The present invention relates to a video transmission system that uses an encoding/decoding technique. An object of the present invention is to refrain from using a memory for storing decoded image data, avoid a decoder input buffer problem (buffer overflow or underflow) with ease, achieve cost reduction, and provide enhanced image quality. In the video transmission system with an encoding/decoding device, a reference signal for adjusting a synchronization schedule of the entire system is generated and supplied to various sections. In addition, a timing adjustment amount for adjusting the synchronization schedule for the reference signal is generated by a decoder and supplied to a camera. | 06-03-2010 |
20110110424 | Video Encoder and Data Processing Method - A video encoder for evaluating a prediction error by using a prediction technique include: an image encoding section which encodes a prediction image; and an encoding control device which selects any one of a plurality of prediction modes in prediction used by the image encoding section. The image encoding section performs clipping of higher-order bits of the prediction error input to the encoding control device and reduction of lower-order bits thereof for each of the prediction modes to control prediction mode selection, thus reducing the prediction error bit width to a predetermined bit width. The encoding control device sets to the image encoding section the number of higher-order bits to be clipped and the number of lower-order bits to be reduced. The predetermined bit width of the prediction error after bit width reduction is matched with the bus width used for prediction error transmission by the encoding control device and the image encoding section. | 05-12-2011 |
20120254881 | PARALLEL COMPUTER SYSTEM AND PROGRAM - There is provided a parallel computer system for performing barrier synchronization using a master node and a plurality of worker nodes based on the time to allow for an adaptive setting of the synchronization time. When a task process in a certain worker node has not been completed by a worker determination time, the particular worker node performs a communication to indicate that the process has not been completed, to a master node. When the communication has been received by a master determination time, the master node performs a communication to indicate that the process time is extended by a correction process time, in order to adjust and extend the synchronization time. In this way, it is possible to reduce the synchronization overhead associated with the execution of an application with a relatively large variation in the process time from a synchronization point to the next synchronization point. | 10-04-2012 |
20130061073 | COMPUTER SYSTEM AND COMPUTER - Disclosed herein is a computer system including multiple worker nodes, each being equipped with an electric power generation unit and an electric power storage unit storing electric power generated by the electric power generation unit, and a master node responsible for management of tasks that are assigned to the worker nodes. Each worker node determines an operating cycle time of the worker node to execute a task assigned by the master node or communicate with any other worker node, based on information indicating a change in electric power stored in the electric power storage unit of the worker node. | 03-07-2013 |
Patent application number | Description | Published |
20080277593 | Ion source - A cathode holder of a tubular shape is inserted into an opening for a cathode of a plasma generating chamber, the cathode holder positioned such that a surface thereof opposes or surrounds a side surface of a cathode. The cathode is held in the cathode holder so that a front surface of the cathode will be positioned on the same plane as, outward from, or inward from the inner wall surface. In the cathode holder is provided a tubular first heat shield surrounding the cathode with a space provided between the first heat shield and the cathode, a surface of the first heat shield positioned to oppose or surround the side surface of the cathode. At a rear end of the cathode is provided a filament. The gap between the cathode holder and the plasma generating chamber is filled with an electrical insulating material. | 11-13-2008 |
20090261248 | ION BEAM APPARATUS AND METHOD EMPLOYING MAGNETIC SCANNING - A multipurpose ion implanter beam line configuration comprising a mass analyzer magnet followed by a magnetic scanner and magnetic collimator combination that introduce bends to the beam path, the beam line constructed for enabling implantation of common monatomic dopant ion species cluster ions, the beam line configuration having a mass analyzer magnet defining a pole gap of substantial width between ferromagnetic poles of the magnet and a mass selection aperture, the analyzer magnet sized to accept an ion beam from a slot-form ion source extraction aperture of at least about 80 mm height and at least about 7 mm width, and to produce dispersion at the mass selection aperture in a plane corresponding to the width of the beam, the mass selection aperture capable of being set to a mass-selection width sized to select a beam of the cluster ions of the same dopant species but incrementally differing molecular weights, the mass selection aperture also capable of being set to a substantially narrower mass-selection width and the analyzer magnet having a resolution at the mass selection aperture sufficient to enable selection of a beam of monatomic dopant ions of substantially a single atomic or molecular weight, the magnetic scanner and magnetic collimator being constructed to successively bend the ion beam in the same sense, which is in the opposite sense to that of the bend introduced by the analyzer magnet of the beam line. | 10-22-2009 |
20110089321 | ION BEAM APPARATUS AND METHOD EMPLOYING MAGNETIC SCANNING - A multipurpose ion implanter beam line configuration comprising a mass analyzer magnet followed by a magnetic scanner and magnetic collimator combination that introduce bends to the beam path, the beam line constructed for enabling implantation of common monatomic dopant ion species cluster ions, the beam line configuration having a mass analyzer magnet defining a pole gap of substantial width between ferromagnetic poles of the magnet and a mass selection aperture, the analyzer magnet sized to accept an ion beam from a slot-form ion source extraction aperture of at least about 80 mm height and at least about 7 mm width, and to produce dispersion at the mass selection aperture in a plane corresponding to the width of the beam, the mass selection aperture capable of being set to a mass-selection width sized to select a beam of the cluster ions of the same dopant species but incrementally differing molecular weights, the mass selection aperture also capable of being set to a substantially narrower mass-selection width and the analyzer magnet having a resolution at the selection aperture sufficient to enable selection of a beam of monatomic dopant ions of substantially a single atomic or molecular weight, the magnetic scanner and magnetic collimator being constructed to successively bend the ion beam in the same sense, which is in the opposite sense to that of the bend introduced by the analyzer magnet of the beam line. | 04-21-2011 |
20140261171 | ION BEAM LINE - In some aspects, an ion implantation system is disclosed that includes an ion source for generating a ribbon ion beam and at least one corrector device for adjusting the current density of the ribbon ion beam along its longitudinal dimension to ensure that the current density profile exhibits a desired uniformity. The ion implantation system can further include other components, such as an analyzer magnet, and electrostatic bend and focusing lenses, to shape and steer the ion beam to an end station for impingement on a substrate. In some embodiments, the present teachings allows the generation of a nominally one-dimensional ribbon beam with a longitudinal size greater than the diameter of a substrate in which ions are implanted with a high degree of longitudinal profile uniformity. | 09-18-2014 |
20140265856 | Magnetic Field Sources For An Ion Source - An ion source is provided that includes an ionization chamber and two magnetic field sources. The ionization chamber has a longitudinal axis extending therethrough and includes two opposing chamber walls, each chamber wall being parallel to the longitudinal axis. The two magnetic field sources each comprises (i) a core and (ii) a coil wound substantially around the core. Each magnetic field source is aligned with and adjacent to an external surface of respective one of the opposing chamber walls and oriented substantially parallel to the longitudinal axis. The cores of the magnetic field sources are physically separated and electrically isolated from each other. | 09-18-2014 |
Patent application number | Description | Published |
20090191181 | METHODS OF MODULATING SMYD3 FOR TREATMENT OF CANCER - The present invention features a method for determining the methyltransferase activity of a polypeptide and screening for modulators of methyltransferase activity, more particularly for modulators of the methylation of retinoblastoma by SMYD3. The invention further provides a method or pharmaceutical composition for prevention or treating of colorectal cancer, hepatocellular carcinoma, bladder cancer and/or breast cancer using a modulator so identified. N-terminal truncated forms of SMYD3 (alias ZNFN3A1) have higher methylating activity. Lys 824 is a preferred methylation site on the RB1 protein for SMYD3. | 07-30-2009 |
20110160293 | PRMT1 FOR TARGET GENES OF CANCER THERAPY AND DIAGNOSIS - Objective methods for diagnosing a predisposition to developing cancer, particularly bladder cancer, gastric cancer, colorectal cancer, breast cancer, esophageal cancer, lung cancer, lymphoma, pancreatic cancer and testicular cancer, are described herein. In one embodiment, the diagnostic method involves determining an expression level of PRMT1 gene. The present invention further provides methods of screening for therapeutic agents useful in the treatment of PRMT1 associated disease, such as a cancer, e.g. bladder cancer, gastric cancer, colorectal cancer, breast cancer, esophageal cancer, lung cancer, lymphoma, pancreatic cancer and testicular cancer. The present invention further provides methods of inhibiting the cell growth and treating or alleviating symptoms of PRMT1 associated diseases. The present invention also features products, including double-stranded molecules and vectors encoding thereof as well as to compositions comprising them. | 06-30-2011 |
20120045766 | JARID1B FOR TARGET GENE OF CANCER THERAPY AND DIAGNOSIS - The present invention relates to the roles played by the JARID1B genes in cancers and features a method for treating cancers by administering a composition comprising a double-stranded molecule against the JARID1B genes or a vector encoding them. The present invention also features methods for diagnosing cancers by detecting the expression of JARID1B. To that end, JARID1B serves as a serological biomarker for cancers. Also, disclosed are methods of identifying candidate agents for treating or preventing cancer or inhibiting cancer cell growth, using the expression of JARID1B in the cancer cells or the cell proliferation resulted from expression of JARID1B as an index. | 02-23-2012 |
20120304318 | CANCER DIAGNOSIS AND TREATMENT - The invention concerns materials and methods relating to the use of OMD (osteomodulin) and\or PRELP (Proline/arginine-rich end leucine-rich repeat protein) expression, particularly under-expression, to discriminate cancer and non-cancer cells in a variety of cancers. The invention further provides methods and materials based on OMD and\or PRELP for use in therapy e.g. to suppress cancer initiation or development. | 11-29-2012 |
20130137748 | WHSC1 AND WHSC1L1 FOR TARGET GENES OF CANCER THERAPY AND DIAGNOSIS - Objective methods for diagnosing a predisposition to developing cancer, for example, bladder cancer, breast cancer, cholangiocellular carcinoma, CML, esophageal cancer, HCC, NSCLC, SCLC, osteosarcoma, pancreatic cancer, prostate cancer, renal cell carcinoma, soft tissue tumor and lymphoma, are described herein. In one embodiment, the diagnostic method involves determining an expression level of a WHSC1 or WHSC1L1 gene. The present invention further provides methods of screening for therapeutic agents useful in the treatment of WHSC1 or WHSC1L1 associated disease, such as a cancer, e.g., bladder cancer, breast cancer, cholangiocellular carcinoma, CML, esophageal cancer, HCC, NSCLC, SCLC, osteosarcoma, pancreatic cancer, prostate cancer, renal cell carcinoma, soft tissue tumor and lymphoma. The present invention further provides methods of inhibiting the cell growth and treating or alleviating symptoms of WHSC1 or WHSC1L1 associated diseases. The present invention also features products, including double-stranded molecules and vectors encoding thereof as well as to compositions including them. Also, disclosed are methods of identifying substances for treating or/and preventing lung cancer, using as an index their effect on expression of a WHSC1 or WHSC1L1 gene, or a biological activity of a WHSC1 or WHSC1L1 polypeptide. | 05-30-2013 |
20130203625 | SUV420H1 AND SUV420H2 AS TARGET GENES FOR CANCER THERAPY AND DIAGNOSIS - The present invention relates to the roles played by the SUV420H1 and SUV420H2 genes in carcinogenesis and features a method for treating or preventing cancer by administering a double-stranded molecule against the SUV420H1 or SUV420H2 gene or a composition or vector containing such a double-stranded molecule. The present invention also features methods and kits for detecting or diagnosing cancer in a subject, including detecting an expression level of the SUV420H1 or SUV420H2 gene. The present invention further features methods and kits for assessing or determining the prognosis of a subject with cancer, including detecting the expression level of an SUV420H2 gene. Also, disclosed are methods of screening for candidate substances for treating or preventing cancer or inhibiting cancer cell growth, using as an index their effect on the expression or activity of SUV420H1 or SUV420H2. | 08-08-2013 |
20140094387 | SUV39H2 AS A TARGET GENE FOR CANCER THERAPY AND DIAGNOSIS - Objective methods for detecting or diagnosing cancer, or determining a predisposition for developing cancer, particularly lung cancer, cervical cancer, bladder cancer, esophageal cancer, osteosarcoma, prostate cancer and soft tissue tumor, are described herein. In one embodiment, the diagnostic method involves determining an expression level of the SUV39H2 gene. The present invention further provides methods of screening for candidate substances useful in the treatment and/or prevention of an SUV39H2-associated cancer, such as lung cancer, cervical cancer, bladder cancer, esophageal cancer, osteosarcoma, prostate cancer and soft tissue tumor. The present invention further provides methods of inhibiting the cell growth and thereby treating or alleviating symptoms of an SUV39H2 associated cancer. The present invention also features double-stranded molecules against the SUV39H2 gene and vectors encoding thereof as well as compositions containing such components and their utility in connection with the treatment and prevention of an SUV39H2-associated cancer. | 04-03-2014 |
20140134637 | METHODS OF MODULATING SMYD3 FOR TREATMENT OF CANCER - The present invention features a method for determining the methyltransferase activity of a polypeptide and screening for modulators of methyltransferase activity, more particularly for modulators of the methylation of retinoblastoma by SMYD3. The invention further provides a method or pharmaceutical composition for prevention or treating of colorectal cancer, hepatocellular carcinoma, bladder cancer and/or breast cancer using a modulator so identified. | 05-15-2014 |
20140308678 | SMYD2 AS A TARGET GENE FOR CANCER THERAPY AND DIAGNOSIS - The present invention arises from the discovery that the SMYD2 gene is both specifically over-expressed in cancer and involved in cancer cell survival. The present invention features methods for detecting or diagnosing the presence of or predisposition for developing cancer, using the SMYD2 gene as a diagnostic marker. The present invention further provides methods of screening for therapeutic substances useful in either or both of the treatment and prevention of cancer. | 10-16-2014 |
Patent application number | Description | Published |
20110090568 | RESIN PARTICLE HAVING MANY RECESSES ON THE SURFACE THEREOF - The present invantion provides a resin particle having many recesses on the surface thereof, which has solvent resistance and heat resistance. More specifically, the present invantion provides a resin particle having many recesses on the surface thereof which is obtained by using a seed particle, wherein a seed particle component in the resin particle has a crosslinked structure. Since the resin particle having many recesses on the surface thereof of the present invention is excellent in solvent resistance and heat resistance in addition to light diffusing properties, the resin particle is appropriate for use, for example, in not only cosmetics containing silicone oil and the like in a preparation, a light diffusing film and a light diffusing sheet prepared by dispersing resin particles as a light diffusing agent in an organic solvent such as 2-butanone and the like in a production process, and a light diffusing plate prepared by kneading at a high shear force the resin patticles as a light diffusing agent with polystyrene or polymethyl methacrylate and the like which melts at a high temperature of approximately 300° C. in a production process. | 04-21-2011 |
20130296547 | METHOD FOR PRODUCING PSEUDOPOLYROTAXANE AQUEOUS DISPERSION - The present invention aims to provide an industrially advantageous method for producing an aqueous dispersion of pseudopolyrotaxane enabling to produce an aqueous dispersion of pseudopolyrotaxane having good fluidity and excellent dispersion stability of the pseudopolyrotaxane particles therein. The present invention relates to a method for producing an aqueous dispersion of pseudopolyrotaxane. The method includes: a mixing step of a dissolving polyethylene glycol and a cyclodextrin in an aqueous medium to prepare a mixed solution; and a cooling step of continuously or intermittently cooling the mixed solution in a state of flux to precipitate pseudopolyrotaxane particles. The pseudopolyrotaxane particles contain the polyethylene glycol which is included in the cavities of the cyclodextrin molecules in a skewered manner. | 11-07-2013 |
20130317209 | METHOD FOR PRODUCING PSEUDOPOLYROTAXANE - The present invention aims to provide an industrially advantageous method of producing a pseudopolyrotaxane with a high inclusion ratio. The present invention relates to a method for producing a pseudopolyrotaxane, including: an inclusion step of mixing a polyethylene glycol and a cyclodextrin in an aqueous medium to form an aqueous dispersion of pseudopolyrotaxane that contains pseudopolyrotaxane particles in which the polyethylene glycol is included in the cavities of the cyclodextrin molecules in a skewered manner; and a drying step of drying the aqueous dispersion of pseudopolyrotaxane produced in the inclusion step to obtain the pseudopolyrotaxane. In the drying step, the aqueous dispersion of pseudopolyrotaxane is dried in a thin film state. | 11-28-2013 |
20130331562 | METHOD FOR PRODUCING REFINED POLYROTAXANE - The present invention aims to provide a method for producing a refined polyrotaxane which includes an industrially advantageous method of producing a polyrotaxane that has excellent storage stability. The method for producing a refined polyrotaxane includes the step of heat-cleaning a polyrotaxane with a cleaning medium, the polyrotaxane containing cyclodextrin molecules, a polyethylene glycol which is included in the cavities of the cyclodextrin molecules in a skewered manner, and a capping group that is placed at each end of the polyethylene glycol and prevents dissociation of the cyclodextrin molecules from the polyethylene glycol. | 12-12-2013 |
20140058078 | POLYROTAXANE COMPOSITION - The present invention aims to provide a polyrotaxane composition having excellent storage stability. The present invention relates to a polyrotaxane composition comprising: a polyrotaxane containing a cyclodextrin, a polyethylene glycol which is included in the cavities of the cyclodextrin molecules in a skewered manner, and a capping group that is placed at each end of the polyethylene glycol and prevents dissociation of the cyclodextrin molecules from the polyethylene glycol; and a polyphenol antioxidant. | 02-27-2014 |
20140066403 | HYDROPHILIC MODIFIED POLYROTAXANE COMPOSITION - The present invention aims to provide a hydrophilic modified polyrotaxane composition having excellent storage stability. The present invention relates to a hydrophilic modified polyrotaxane composition comprising: a hydrophilic modified polyrotaxane produced by modifying, with hydrophilic modifying groups, all or part of hydroxy groups on a cyclodextrin of a polyrotaxane containing the cyclodextrin, a polyethylene glycol which is included in the cavities of the cyclodextrin molecules in a skewered manner, and a capping group that is placed at each end of the polyethylene glycol and prevents dissociation of the cyclodextrin molecules from the polyethylene glycol; and a polyphenol antioxidant. | 03-06-2014 |
20140066615 | PRODUCTION METHOD FOR POWDERED HYDROPHILIC MODIFIED POLYROTAXANE - The present invention aims to provide a method of producing a powdered hydrophilic modified polyrotaxane, which enables production of a powdered hydrophilic modified polyrotaxane excellent in storage stability in an industrially advantageous way. The present invention provides a method of producing a powdered hydrophilic modified polyrotaxane, comprising: a hydrophilic modification step of preparing a solution of a hydrophilic modified polyrotaxane by modifying all or part of hydroxy groups on a cyclodextrin of a polyrotaxane with hydrophilic modifying groups, the polyrotaxane containing the cyclodextrin, a polyethylene glycol included in the cavities of the cyclodextrin molecules in a skewered manner, and a capping group that is placed at each end of the polyethylene glycol and prevents dissociation of the cyclodextrin molecules from the polyethylene glycol; and a drying step of spraying the prepared solution of the hydrophilic modified polyrotaxane and drying the solution of the hydrophilic modified polyrotaxane in a heated gas stream. | 03-06-2014 |
20140066616 | PRODUCTION METHOD FOR HYDROPHILIC MODIFIED POLYROTAXANE - The present invention aims to provide a method of producing a hydrophilic modified polyrotaxane, which enables production of a hydrophilic modified polyrotaxane excellent in storage stability in an industrially advantageous way. The present invention provides a method of producing a hydrophilic modified polyrotaxane, comprising: a hydrophilic modification step of preparing a solution of a hydrophilic modified polyrotaxane by modifying all or part of hydroxy groups on a cyclodextrin of a polyrotaxane with hydrophilic modifying groups, the polyrotaxane containing the cyclodextrin, a polyethylene glycol included in the cavities of the cyclodextrin molecules in a skewered manner, and a capping group that is placed at each end of the polyethylene glycol and prevents dissociation of the cyclodextrin molecules from the polyethylene glycol; and a drying step in which the prepared solution of the hydrophilic modified polyrotaxane is formed into a thin film state and dried. | 03-06-2014 |
Patent application number | Description | Published |
20080254527 | VON WILLEBRAND FACTOR (vWF) - CLEAVING PROTEASE - This invention is intended to isolate and identify a vWF-specific cleaving protease. The vWF-specific cleaving protease cleaves a bond between residues Tyr 842 and Met 843 of vWF and comprises a polypeptide chain having Leu-Leu-Val-Ala-Val (SEQ ID NO: 1) as a partial sequence, and more preferably comprises a polypeptide chain having the partial N-terminal amino acid sequence of a mature protein, Ala-Ala-Gly-Gly-Ile-Leu-His-Leu-Glu-Leu-Leu-Val-Ala-Val (SEQ ID NO: 2), and having a molecular weight of 105 to 160 kDa in SDS-PAGE under reducing or non-reducing conditions. Isolation and identification of this vWF-specific cleaving protease have led to the possibility of replacement therapy for patients having diseases resulting from a deficiency of the protease, such as thrombotic thrombocytopenic purpura. | 10-16-2008 |
20120225818 | PLASMA PROTEIN EFFECTIVE FOR SUPPRESSING COUGH - The activated Factor XI is provided as an antitussive for cough caused by the stimulation at the tracheal bifurcation such as chronic cough. A pharmaceutical composition for prevention, treatment and/or symptom amelioration of cough, comprising a polypeptide chain as an active ingredient and a pharmaceutically acceptable carrier, wherein the polypeptide chain consists of a full length amino acid sequence constituting activated Factor XI (hereinafter also referred to as “FXIa”), the amino acid sequence with one or several amino acids therein being deleted, substituted or added, or a partial sequence of either of the above amino acid sequences, or an amino acid sequence comprising as a part any of the above amino acid sequences. | 09-06-2012 |
20130041137 | von Willebrand Factor (vWF) - Cleaving Protease - This invention is intended to isolate and identify a vWF-specific cleaving protease. The vWF-specific cleaving protease cleaves a bond between residues Tyr 842 and Met 843 of vWF and comprises a polypeptide chain having Leu-Leu-Val-Ala-Val (SEQ ID NO: 1) as a partial sequence, and more preferably comprises a polypeptide chain having the partial N-terminal amino acid sequence of a mature protein, Ala-Ala-Gly-Gly-Ile-Leu-His-Leu-Glu-Leu-Leu-Val-Ala-Val (SEQ ID NO: 2), and having a molecular weight of 105 to 160 kDa in SDS-PAGE under reducing or non-reducing conditions. Isolation and identification of this vWF-specific cleaving protease have led to the possibility of replacement therapy for patients having diseases resulting from a deficiency of the protease, such as thrombotic thrombocytopenic purpura. | 02-14-2013 |
20130224179 | PLASMA PROTEIN EFFECTIVE FOR SUPPRESSING COUGH - The activated Factor XI is provided as an antitussive for cough caused by the stimulation at the tracheal bifurcation such as chronic cough. A pharmaceutical composition for prevention, treatment and/or symptom amelioration of cough, comprising a polypeptide chain as an active ingredient and a pharmaceutically acceptable carrier, wherein the polypeptide chain consists of a full length amino acid sequence constituting activated Factor XI (hereinafter also referred to as “FXIa”), the amino acid sequence with one or several amino acids therein being deleted, substituted or added, or a partial sequence of either of the above amino acid sequences, or an amino acid sequence comprising as a part any of the above amino acid sequences. | 08-29-2013 |
Patent application number | Description | Published |
20100028304 | PESTICIDAL COMPOSITIONS - A pesticidal composition comprising synergistically effective amounts of at least one anthranilamide compound represented by the formula (I) or its salt and other pesticide: wherein each of R | 02-04-2010 |
20100087452 | PYRIDYL-TRIAZOLOPYRIMIDINE DERIVATIVE OR ITS SALT, PESTICIDE CONTAINING IT AND ITS PRODUCTION PROCESS - To provide a novel pesticide. The present invention provides a pesticide containing a pyridyl-triazolopyrimidine derivative represented by the formula (I) or its salt as an active ingredient: wherein R | 04-08-2010 |
20100179172 | N-PHENYL-METHANAMINE DERIVATIVE AND PESTICIDE CONTAINING IT - A novel pesticide is provided. The present invention provides a pesticide containing, as an active ingredient, an N-phenyl-methanamine derivative represented by the formula (I) or its salt: | 07-15-2010 |
20100317700 | PESTICIDAL COMPOSITIONS - To provide a formulation composition which improves the controlling effect of an anthranilamide compound against pests. A pesticide composition which is a concentrated composition containing an anthranilamide compound as a pesticidal active ingredient, a dispersant and a hydrophilic organic solvent, characterized in that when the composition is diluted with water, the anthranilamide compound precipitates as solid particles in water. | 12-16-2010 |
20110015237 | SOLID COMPOSITION FOR PEST CONTROL - To provide an anthranilamide formulation compound for improving pest controlling effects. | 01-20-2011 |
20110130427 | PESTICIDAL COMPOSITION - To improve the controlling effects of anthranilamide compounds against pests. A pesticidal composition comprising, as active ingredients, an anthranilamide compound or its salt, and a polyoxyalkylene phosphoric acid ester surfactant, and a method for controlling a pest by using such a composition, are provided. Further, a method for improving the pesticidal effects of an anthranilamide compound or its salt, as an active ingredient, by means of a polyoxyalkylene phosphoric acid ester surfactant, is provided. | 06-02-2011 |
Patent application number | Description | Published |
20080254367 | LITHIUM SECONDARY BATTERY AND NON-AQUEOUS ELECTROLYTIC SOLUTION - The sudden generation of heat being frequently caused in the case of the overcharge of a lithium secondary cell which have a positive electrode comprising a composite metal oxide of lithium and cobalt or a composite metal oxide of lithium and nickel, a negative electrode comprising metallic lithium, a lithium alloy or a material capable of occluding and releasing lithium, and a nonaqueous electrolyte solution comprising a nonaqueous solvent and an electrolyte dissolved therein can be efficiently prevented by the addition, to the nonaqueous electrolyte solution, of an organic compound which, when the lithium secondary cell is overcharged, decomposes into a decomposition product capable of dissolving out the cobalt or nickel contained in the positive electrode and depositing it ion the negative electrode (for example, a tert-alkylbenzene derivative). | 10-16-2008 |
20100079110 | NON-AQUEOUS ELECTROLYTIC SOLUTION AND LITHIUM SECONDARY BATTERY - A non-aqueous electrolytic solution favorably employable for a lithium secondary battery employs a non-aqueous electrolytic solution which comprises a non-aqueous solvent and an electrolyte which further contains 0.001 to 0.8 weight % of a biphenyl derivative having the formula: | 04-01-2010 |
20110250504 | LITHIUM SECONDARY BATTERY AND NON-AQUEOUS ELECTROLYTIC SOLUTION - The sudden generation of heat being frequently caused in the case of the overcharge of a lithium secondary cell which have a positive electrode comprising a composite metal oxide of lithium and cobalt or a composite metal oxide of lithium and nickel, a negative electrode comprising metallic lithium, a lithium alloy or a material capable of occluding and releasing lithium, and a nonaqueous electrolyte solution comprising a nonaqueous solvent and an electrolyte dissolved therein can be efficiently prevented by the addition, to the nonaqueous electrolyte solution, of an organic compound which, when the lithium secondary cell is overcharged, decomposes into a decomposition product capable of dissolving out the cobalt or nickel contained in the positive electrode and depositing it ion the negative electrode (for example, a tert-alkylbenzene derivative). | 10-13-2011 |
Patent application number | Description | Published |
20080319711 | Effective factor extraction system and its method and program - To provide an effective factor extraction system in which samples are generated artificially from a sample group and a virtual sample set is created so that even when the number of sample is relatively small, specific factors can be selected/extracted with high reliability by using the virtual sample set. The effective factor extraction system comprises a section ( | 12-25-2008 |
20100304372 | Liver Cancer Methods and Compositions - The present invention provides a novel method for detection of liver cancer. This method detects high-sensitively, high-specifically, simply and accurately liver cancer, especially that in early stage by identifying and/or quantifying methylation on particular genes and/or their DNA fragments in clinical specimens, and by combining said methylated DNA values with existing tumor marker values and/or DNA amounts in blood. This invention also detects a precancerous lesion, detects a risk of recurrence after treatment of liver cancer, detects malignancy of liver cancer and monitors progression of liver cancer with time by the same method. As for particular genes, BASP1 gene, SPINT2 gene, APC gene, CCND2 gene, CFTR gene, RASSF1 gene and SRD5A2 gene are mentioned. | 12-02-2010 |
20110288783 | SYSTEM FOR PREDICTING DRUG EFFECTS AND ADVERSE EFFECTS AND PROGRAM FOR THE SAME - A drug effect-adverse effect prediction system includes a clinical data analysis table generating part, for each combination of genotypes relating to a drug effect or adverse effect, for generation of an analysis table for handling cases related to presence or absence of the drug effect or adverse effect. The system also includes a reliability analysis part, a discrimination formula generating part, a prediction part, and a discrimination formula optimizing part. | 11-24-2011 |
20120065892 | SCORING SYSTEM FOR THE PREDICTION OF CANCER RECURRENCE - The present invention relates to a scoring system for the prediction of cancer recurrence by selecting genes and/or proteins whose expression patterns associated with recurrence of cancer, and generating formulae with the selected genes and/or proteins for the prediction of cancer recurrence. The present invention relates to a kit for determining the likelihood of recurrence of cancer, comprising DNA chip, oligonucleotide chip, protein chip, peptides, antibodies, probes and primers that are necessary for effecting DNA microarrays, oligonucleotide microarrays, protein arrays, northern blotting, in situ hybridization, RNase protection assays, western blotting, ELISA assays, reverse transcription polymerase-chain reaction to examine the expression of at least 2, 4, 6, 10, 12 or more genes and/or proteins, that are indicative of cancer recurrence. | 03-15-2012 |